Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK expands skin care portfolio

This article was originally published in The Tan Sheet

Executive Summary

Consumer Healthcare division acquires five Rx topical dermatological products from Elan Pharmaceuticals, GSK announces Dec. 23. Firm will market Temovate, Emgel, Aclovate, Cutivate and Oxistat beginning Jan. 1, noting brands "are an excellent fit with" GSK's current OTC dermatology products Oxy (for acne)and Abreva (for cold sores). Firm expects "medical marketing expertise" gained from co-marketing Rx products such as Bactroban will add to success of acquisition. According to GSK, Elan reported the five products generated sales of $62 mil. in 2001...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS094965

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel